APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Adeno-Associated Virus (AAV) Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Custom Adeno-Associated Virus (AAV) Services Market Analysis and Forecast 2026-2032

3 May 2026225 pages

Choose your research edition.

Industry ResearchCustom Adeno-Associated Virus (AAV) Services Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Adeno-Associated Virus (AAV) Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Custom Adeno-Associated Virus (AAV) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Adeno-Associated Virus (AAV) Services Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Adeno-Associated Virus (AAV) Services Market Analysis and Forecast 2026-2032225 pages · $4,950 USD

Market perspective

The global Custom Adeno-Associated Virus (AAV) Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Adeno-Associated Virus (AAV) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Custom Adeno-Associated Virus (AAV) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Custom Adeno-Associated Virus (AAV) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Custom Adeno-Associated Virus (AAV) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Custom Adeno-Associated Virus (AAV) Services include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed） and Gene Universal, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Adeno-Associated Virus (AAV) Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Custom Adeno-Associated Virus (AAV) Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Adeno-Associated Virus (AAV) Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Adeno-Associated Virus (AAV) Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Adeno-Associated Virus (AAV) Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Adeno-Associated Virus (AAV) Services revenue, projected growth trends, production technology, application and end-user industry.

Custom Adeno-Associated Virus (AAV) Services Segment by Company

Thermo Fisher Scientific

Lonza

Catalent

Charles River

Merck

SK pharmteco

Oxford Biomedica

AGC Biologics（MolMed）

Gene Universal

Polyplus (Sartorius)

CCRM

FUJIFILM Diosynth Biotechnologies

Biovian

Miltenyi Bioindustry

Aldevron

Takara Bio

Yposkesi

Genezen

Exthera

GenScript ProBio

EurekaBio

Obio Technology

GeneSail Biotech

VectorBuilder

WuXi ATU

Ubrigene

Porton Biologics

Pharmaron

PackGene Biotechnology

Custom Adeno-Associated Virus (AAV) Services Segment by Type

Adherent Culture

Suspension Culture

Custom Adeno-Associated Virus (AAV) Services Segment by Application

Vaccine Development

Gene Therapy

Academic Scientific Research Institution

Others

Custom Adeno-Associated Virus (AAV) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Adeno-Associated Virus (AAV) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Adeno-Associated Virus (AAV) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Adeno-Associated Virus (AAV) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Custom Adeno-Associated Virus (AAV) Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Custom Adeno-Associated Virus (AAV) Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Adeno-Associated Virus (AAV) Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adherent Culture Major Player Table 3. Suspension Culture Major Player Table 4. Global Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Vaccine Development Major Player Table 6. Gene Therapy Major Player Table 7. Academic Scientific Research Institution Major Player Table 8. Others Major Player Table 9. Custom Adeno-Associated Virus (AAV) Services Industry Trends Table 10. Custom Adeno-Associated Virus (AAV) Services Industry Drivers Table 11. Custom Adeno-Associated Virus (AAV) Services Industry Opportunities and Challenges Table 12. Custom Adeno-Associated Virus (AAV) Services Industry Restraints Table 13. Global Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region (2021-2026) Table 16. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region (2027-2032) Table 18. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Players (2021-2026) Table 20. Global Custom Adeno-Associated Virus (AAV) Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Custom Adeno-Associated Virus (AAV) Services Key Players Headquarters & Area Served Table 22. Global Custom Adeno-Associated Virus (AAV) Services Players, Product Type & Application Table 23. Global Custom Adeno-Associated Virus (AAV) Services Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Custom Adeno-Associated Virus (AAV) Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Type (2021-2026) Table 30. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Type (2027-2032) Table 31. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Application (2021-2026) Table 35. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Application (2027-2032) Table 36. Thermo Fisher Scientific Company Information Table 37. Thermo Fisher Scientific Business Overview Table 38. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 40. Thermo Fisher Scientific Recent Development Table 41. Lonza Company Information Table 42. Lonza Business Overview Table 43. Lonza Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 45. Lonza Recent Development Table 46. Catalent Company Information Table 47. Catalent Business Overview Table 48. Catalent Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 50. Catalent Recent Development Table 51. Charles River Company Information Table 52. Charles River Business Overview Table 53. Charles River Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 55. Charles River Recent Development Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 60. Merck Recent Development Table 61. SK pharmteco Company Information Table 62. SK pharmteco Business Overview Table 63. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 65. SK pharmteco Recent Development Table 66. Oxford Biomedica Company Information Table 67. Oxford Biomedica Business Overview Table 68. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 70. Oxford Biomedica Recent Development Table 71. AGC Biologics（MolMed） Company Information Table 72. AGC Biologics（MolMed） Business Overview Table 73. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 75. AGC Biologics（MolMed） Recent Development Table 76. Gene Universal Company Information Table 77. Gene Universal Business Overview Table 78. Gene Universal Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 80. Gene Universal Recent Development Table 81. Polyplus (Sartorius) Company Information Table 82. Polyplus (Sartorius) Business Overview Table 83. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 85. Polyplus (Sartorius) Recent Development Table 86. CCRM Company Information Table 87. CCRM Business Overview Table 88. CCRM Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 90. CCRM Recent Development Table 91. FUJIFILM Diosynth Biotechnologies Company Information Table 92. FUJIFILM Diosynth Biotechnologies Business Overview Table 93. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 95. FUJIFILM Diosynth Biotechnologies Recent Development Table 96. Biovian Company Information Table 97. Biovian Business Overview Table 98. Biovian Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 100. Biovian Recent Development Table 101. Miltenyi Bioindustry Company Information Table 102. Miltenyi Bioindustry Business Overview Table 103. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 105. Miltenyi Bioindustry Recent Development Table 106. Aldevron Company Information Table 107. Aldevron Business Overview Table 108. Aldevron Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 110. Aldevron Recent Development Table 111. Takara Bio Company Information Table 112. Takara Bio Business Overview Table 113. Takara Bio Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 115. Takara Bio Recent Development Table 116. Yposkesi Company Information Table 117. Yposkesi Business Overview Table 118. Yposkesi Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 120. Yposkesi Recent Development Table 121. Genezen Company Information Table 122. Genezen Business Overview Table 123. Genezen Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 125. Genezen Recent Development Table 126. Exthera Company Information Table 127. Exthera Business Overview Table 128. Exthera Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 130. Exthera Recent Development Table 131. GenScript ProBio Company Information Table 132. GenScript ProBio Business Overview Table 133. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 135. GenScript ProBio Recent Development Table 136. EurekaBio Company Information Table 137. EurekaBio Business Overview Table 138. EurekaBio Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 140. EurekaBio Recent Development Table 141. Obio Technology Company Information Table 142. Obio Technology Business Overview Table 143. Obio Technology Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 145. Obio Technology Recent Development Table 146. GeneSail Biotech Company Information Table 147. GeneSail Biotech Business Overview Table 148. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 150. GeneSail Biotech Recent Development Table 151. VectorBuilder Company Information Table 152. VectorBuilder Business Overview Table 153. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 155. VectorBuilder Recent Development Table 156. WuXi ATU Company Information Table 157. WuXi ATU Business Overview Table 158. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 160. WuXi ATU Recent Development Table 161. Ubrigene Company Information Table 162. Ubrigene Business Overview Table 163. Ubrigene Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 165. Ubrigene Recent Development Table 166. Porton Biologics Company Information Table 167. Porton Biologics Business Overview Table 168. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 170. Porton Biologics Recent Development Table 171. Pharmaron Company Information Table 172. Pharmaron Business Overview Table 173. Pharmaron Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 175. Pharmaron Recent Development Table 176. PackGene Biotechnology Company Information Table 177. PackGene Biotechnology Business Overview Table 178. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 180. PackGene Biotechnology Recent Development Table 181. North America Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026) & (US$ Million) Table 182. North America Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032) & (US$ Million) Table 183. North America Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026) & (US$ Million) Table 184. North America Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032) & (US$ Million) Table 185. North America Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. North America Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021-2026) & (US$ Million) Table 187. North America Custom Adeno-Associated Virus (AAV) Services Revenue by Country (US$ Million) & (2027-2032) Table 188. Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026) & (US$ Million) Table 189. Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032) & (US$ Million) Table 190. Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026) & (US$ Million) Table 191. Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032) & (US$ Million) Table 192. Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021-2026) & (US$ Million) Table 194. Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Country (US$ Million) & (2027-2032) Table 195. China Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026) & (US$ Million) Table 196. China Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032) & (US$ Million) Table 197. China Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026) & (US$ Million) Table 198. China Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026) & (US$ Million) Table 200. Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032) & (US$ Million) Table 201. Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Region (US$ Million) & (2021-2026) Table 205. Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Region (US$ Million) & (2027-2032) Table 206. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021-2026) & (US$ Million) Table 212. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Country (US$ Million) & (2027-2032) Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Custom Adeno-Associated Virus (AAV) Services Image Figure 2. Global Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Adeno-Associated Virus (AAV) Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adherent Culture Image Figure 5. Suspension Culture Image Figure 6. Global Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Custom Adeno-Associated Virus (AAV) Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Vaccine Development Image Figure 9. Gene Therapy Image Figure 10. Academic Scientific Research Institution Image Figure 11. Others Image Figure 12. Global Custom Adeno-Associated Virus (AAV) Services Market Size (US$ Million) & (2021-2032) Figure 13. Global Custom Adeno-Associated Virus (AAV) Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Custom Adeno-Associated Virus (AAV) Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Type (2021-2032) Figure 20. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Application (2021-2032) Figure 23. North America Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032) Figure 25. North America Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032) Figure 26. North America Custom Adeno-Associated Virus (AAV) Services Revenue Share by Country (2021-2032) Figure 27. United States Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032) Figure 32. Europe Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032) Figure 33. Europe Custom Adeno-Associated Virus (AAV) Services Revenue Share by Country (2021-2032) Figure 34. Germany Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032) Figure 44. China Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032) Figure 45. Asia Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032) Figure 47. Asia Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032) Figure 48. Asia Custom Adeno-Associated Virus (AAV) Services Revenue Share by Region (2021-2032) Figure 49. Japan Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032) Figure 57. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032) Figure 58. SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue Share by Country (2021-2032) Figure 59. Brazil Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Custom Adeno-Associated Virus (AAV) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Adherent Culture
  • Suspension Culture
Applications
  • Vaccine Development
  • Gene Therapy
  • Academic Scientific Research Institution
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Lonza
  • Catalent
  • Charles River
  • Merck
  • SK pharmteco
  • Oxford Biomedica
  • AGC Biologics（MolMed）
  • Gene Universal
  • Polyplus (Sartorius)
  • CCRM
  • FUJIFILM Diosynth Biotechnologies
  • Biovian
  • Miltenyi Bioindustry
  • Aldevron
  • Takara Bio
  • Yposkesi
  • Genezen
  • Exthera
  • GenScript ProBio
  • EurekaBio
  • Obio Technology
  • GeneSail Biotech
  • VectorBuilder
  • WuXi ATU
  • Ubrigene
  • Porton Biologics
  • Pharmaron
  • PackGene Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Custom Adeno-Associated Virus (AAV) Services Market by Type
  3. 1.2.1 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adherent Culture
  5. 1.2.3 Suspension Culture
  6. 1.3 Custom Adeno-Associated Virus (AAV) Services Market by Application
  7. 1.3.1 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Vaccine Development
  9. 1.3.3 Gene Therapy
  10. 1.3.4 Academic Scientific Research Institution
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Custom Adeno-Associated Virus (AAV) Services Market Dynamics
  1. 2.1 Custom Adeno-Associated Virus (AAV) Services Industry Trends
  2. 2.2 Custom Adeno-Associated Virus (AAV) Services Industry Drivers
  3. 2.3 Custom Adeno-Associated Virus (AAV) Services Industry Opportunities and Challenges
  4. 2.4 Custom Adeno-Associated Virus (AAV) Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Custom Adeno-Associated Virus (AAV) Services Market Perspective (2021-2032)
  2. 3.2 Global Custom Adeno-Associated Virus (AAV) Services Growth Trends by Region
  3. 3.2.1 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Players
  2. 4.1.1 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Custom Adeno-Associated Virus (AAV) Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Custom Adeno-Associated Virus (AAV) Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Custom Adeno-Associated Virus (AAV) Services Key Players Headquarters & Area Served
  7. 4.4 Global Custom Adeno-Associated Virus (AAV) Services Players, Product Type & Application
  8. 4.5 Global Custom Adeno-Associated Virus (AAV) Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Custom Adeno-Associated Virus (AAV) Services Market CR5 and HHI
  11. 4.6.3 2025 Custom Adeno-Associated Virus (AAV) Services Tier 1, Tier 2, and Tier 3
5 Custom Adeno-Associated Virus (AAV) Services Market Size by Type
  1. 5.1 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2032)
  3. 5.3 Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Type (2021-2032)
6 Custom Adeno-Associated Virus (AAV) Services Market Size by Application
  1. 6.1 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2032)
  3. 6.3 Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Lonza
  8. 7.2.1 Lonza Company Information
  9. 7.2.2 Lonza Business Overview
  10. 7.2.3 Lonza Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  12. 7.2.5 Lonza Recent Developments
  13. 7.3 Catalent
  14. 7.3.1 Catalent Company Information
  15. 7.3.2 Catalent Business Overview
  16. 7.3.3 Catalent Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  18. 7.3.5 Catalent Recent Developments
  19. 7.4 Charles River
  20. 7.4.1 Charles River Company Information
  21. 7.4.2 Charles River Business Overview
  22. 7.4.3 Charles River Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  24. 7.4.5 Charles River Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 SK pharmteco
  32. 7.6.1 SK pharmteco Company Information
  33. 7.6.2 SK pharmteco Business Overview
  34. 7.6.3 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  36. 7.6.5 SK pharmteco Recent Developments
  37. 7.7 Oxford Biomedica
  38. 7.7.1 Oxford Biomedica Company Information
  39. 7.7.2 Oxford Biomedica Business Overview
  40. 7.7.3 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  42. 7.7.5 Oxford Biomedica Recent Developments
  43. 7.8 AGC Biologics（MolMed）
  44. 7.8.1 AGC Biologics（MolMed） Company Information
  45. 7.8.2 AGC Biologics（MolMed） Business Overview
  46. 7.8.3 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  48. 7.8.5 AGC Biologics（MolMed） Recent Developments
  49. 7.9 Gene Universal
  50. 7.9.1 Gene Universal Company Information
  51. 7.9.2 Gene Universal Business Overview
  52. 7.9.3 Gene Universal Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  54. 7.9.5 Gene Universal Recent Developments
  55. 7.10 Polyplus (Sartorius)
  56. 7.10.1 Polyplus (Sartorius) Company Information
  57. 7.10.2 Polyplus (Sartorius) Business Overview
  58. 7.10.3 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  60. 7.10.5 Polyplus (Sartorius) Recent Developments
  61. 7.11 CCRM
  62. 7.11.1 CCRM Company Information
  63. 7.11.2 CCRM Business Overview
  64. 7.11.3 CCRM Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  66. 7.11.5 CCRM Recent Developments
  67. 7.12 FUJIFILM Diosynth Biotechnologies
  68. 7.12.1 FUJIFILM Diosynth Biotechnologies Company Information
  69. 7.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
  70. 7.12.3 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  72. 7.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  73. 7.13 Biovian
  74. 7.13.1 Biovian Company Information
  75. 7.13.2 Biovian Business Overview
  76. 7.13.3 Biovian Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  78. 7.13.5 Biovian Recent Developments
  79. 7.14 Miltenyi Bioindustry
  80. 7.14.1 Miltenyi Bioindustry Company Information
  81. 7.14.2 Miltenyi Bioindustry Business Overview
  82. 7.14.3 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  84. 7.14.5 Miltenyi Bioindustry Recent Developments
  85. 7.15 Aldevron
  86. 7.15.1 Aldevron Company Information
  87. 7.15.2 Aldevron Business Overview
  88. 7.15.3 Aldevron Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  90. 7.15.5 Aldevron Recent Developments
  91. 7.16 Takara Bio
  92. 7.16.1 Takara Bio Company Information
  93. 7.16.2 Takara Bio Business Overview
  94. 7.16.3 Takara Bio Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  96. 7.16.5 Takara Bio Recent Developments
  97. 7.17 Yposkesi
  98. 7.17.1 Yposkesi Company Information
  99. 7.17.2 Yposkesi Business Overview
  100. 7.17.3 Yposkesi Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  102. 7.17.5 Yposkesi Recent Developments
  103. 7.18 Genezen
  104. 7.18.1 Genezen Company Information
  105. 7.18.2 Genezen Business Overview
  106. 7.18.3 Genezen Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  108. 7.18.5 Genezen Recent Developments
  109. 7.19 Exthera
  110. 7.19.1 Exthera Company Information
  111. 7.19.2 Exthera Business Overview
  112. 7.19.3 Exthera Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  114. 7.19.5 Exthera Recent Developments
  115. 7.20 GenScript ProBio
  116. 7.20.1 GenScript ProBio Company Information
  117. 7.20.2 GenScript ProBio Business Overview
  118. 7.20.3 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  120. 7.20.5 GenScript ProBio Recent Developments
  121. 7.21 EurekaBio
  122. 7.21.1 EurekaBio Company Information
  123. 7.21.2 EurekaBio Business Overview
  124. 7.21.3 EurekaBio Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  125. 7.21.4 EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  126. 7.21.5 EurekaBio Recent Developments
  127. 7.22 Obio Technology
  128. 7.22.1 Obio Technology Company Information
  129. 7.22.2 Obio Technology Business Overview
  130. 7.22.3 Obio Technology Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  132. 7.22.5 Obio Technology Recent Developments
  133. 7.23 GeneSail Biotech
  134. 7.23.1 GeneSail Biotech Company Information
  135. 7.23.2 GeneSail Biotech Business Overview
  136. 7.23.3 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  137. 7.23.4 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  138. 7.23.5 GeneSail Biotech Recent Developments
  139. 7.24 VectorBuilder
  140. 7.24.1 VectorBuilder Company Information
  141. 7.24.2 VectorBuilder Business Overview
  142. 7.24.3 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  143. 7.24.4 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  144. 7.24.5 VectorBuilder Recent Developments
  145. 7.25 WuXi ATU
  146. 7.25.1 WuXi ATU Company Information
  147. 7.25.2 WuXi ATU Business Overview
  148. 7.25.3 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  149. 7.25.4 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  150. 7.25.5 WuXi ATU Recent Developments
  151. 7.26 Ubrigene
  152. 7.26.1 Ubrigene Company Information
  153. 7.26.2 Ubrigene Business Overview
  154. 7.26.3 Ubrigene Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  156. 7.26.5 Ubrigene Recent Developments
  157. 7.27 Porton Biologics
  158. 7.27.1 Porton Biologics Company Information
  159. 7.27.2 Porton Biologics Business Overview
  160. 7.27.3 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  162. 7.27.5 Porton Biologics Recent Developments
  163. 7.28 Pharmaron
  164. 7.28.1 Pharmaron Company Information
  165. 7.28.2 Pharmaron Business Overview
  166. 7.28.3 Pharmaron Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  168. 7.28.5 Pharmaron Recent Developments
  169. 7.29 PackGene Biotechnology
  170. 7.29.1 PackGene Biotechnology Company Information
  171. 7.29.2 PackGene Biotechnology Business Overview
  172. 7.29.3 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  173. 7.29.4 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  174. 7.29.5 PackGene Biotechnology Recent Developments
8 North America
  1. 8.1 North America Custom Adeno-Associated Virus (AAV) Services Revenue (2021-2032)
  2. 8.2 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032)
  5. 8.3 North America Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032)
  9. 8.5 North America Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Country
  11. 8.6.1 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Custom Adeno-Associated Virus (AAV) Services Revenue (2021-2032)
  2. 9.2 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032)
  5. 9.3 Europe Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032)
  9. 9.5 Europe Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Country
  11. 9.6.1 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Custom Adeno-Associated Virus (AAV) Services Revenue (2021-2032)
  2. 10.2 China Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2032)
  3. 10.2.1 China Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026)
  4. 10.2.2 China Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032)
  5. 10.3 China Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032)
  6. 10.4 China Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2032)
  7. 10.4.1 China Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026)
  8. 10.4.2 China Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032)
  9. 10.5 China Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Custom Adeno-Associated Virus (AAV) Services Revenue (2021-2032)
  2. 11.2 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032)
  5. 11.3 Asia Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032)
  9. 11.5 Asia Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Country
  11. 11.6.1 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue (2021-2032)
  2. 12.2 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Country
  11. 12.6.1 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Custom Adeno-Associated Virus (AAV) Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst